An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
UPMC Shadyside Hospital, Pittsburgh, Pennsylvania, United States
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Peking University First Hospital, Beijing, Beijing, China
Westwood Open MRI, Los Angeles, California, United States
Neurological Associates of West Los Angeles, Santa Monica, California, United States
Department of Anesthesia, Surgical ICU, and Pain Management, Cairo, Egypt
Ain Shams University hosptal, Cairo, Abbasya, Egypt
Asklepieion Hospital of Voula, Athens, Greece
Renji Hospital,Shanghai Jiao Tong University,School of Medicine, Shanghai, Shanghai, China
Ajou university school of medicine, Suwon, Gyeonggi-do, Korea, Republic of
DUHS, Civil hospital Karachi (CHK), Karachi, Sindh, Pakistan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.